Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

Clinical trial NCT04872621 · COMPLETED

Trial details

NCT number: NCT04872621
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)

Start date: 2021-06-30
Primary completion: 2024-09-04
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.